Skip to main content
Erschienen in: Supportive Care in Cancer 6/2024

01.06.2024 | Research

Fine-tuning the needle: analysis of acupuncturist response to alarming events during gynecological oncology surgery

verfasst von: Eran Ben-Arye, Galit Galil, Noah Samuels, Yakir Segev, Meirav Schmidt, Orit Gressel

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

Examining an intra-operative acupuncture/acupressure setting, with real-time “fine-tuning” in response to alarming events (AEvs) during gynecological oncology surgery.

Methods

Narratives of acupuncturists providing intraoperative acupuncture during gynecological oncology surgery were qualitatively analyzed. These described real time “fine-tuning” in response to AEvs during surgery, identified through hemodynamic changes (e.g., systolic/diastolic arterial pressure); bispectral index (BIS) elevation; and feedback from surgeons and anesthesiologists. Documentation of acupuncturist responses to AEvs was addressed as well.

Results

Of the 48 patients in the cohort, 33 had at least one intraoperative AEv (69%), of which 30 were undergoing laparoscopic surgery and 18 laparotomies. A total of 77 AEvs were documented throughout surgery (range 1–7; mean: 2.3 events per patient), identified through increased (63 events) or decreased (8) mean arterial pressure (MAP); increased BIS levels (2), or other hemodynamic parameters (4). Integrative oncology interventions implemented in response to AEs included acupressure alone (59); combining acupressure with acupuncture (10); or acupuncture alone (4). In 54 (70%) events, documentation was provided from beginning to conclusion of the AEv, with a mean duration of 9.7 min, with 32 events including a documented anesthesiologist intervention.

Conclusion

The present study demonstrated the feasibility of intraoperative acupuncture with acupressure, with ongoing “fine-tuning” to AEvs identified through objective pain-related parameters (MAP, heart rate and BIS) and real-time input from surgeons and anesthesiologists. Documentation of the intraoperative IO practitioner’s response to these AEvs is important, and should be addressed in future research of the innovative integrative model of care.
Trial registration number: CMC-18-0037 (Carmel Medical Center, June 11, 2018)
Literatur
2.
Zurück zum Zitat Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E (2022) Integrative medicine for pain management in oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol 40(34):3998–4024. https://doi.org/10.1200/JCO.22.01357CrossRefPubMed Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E (2022) Integrative medicine for pain management in oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol 40(34):3998–4024. https://​doi.​org/​10.​1200/​JCO.​22.​01357CrossRefPubMed
3.
Zurück zum Zitat Lesi G, Razzini G, Musti MA, Stivanello E, Petrucci C, Benedetti B, Rondini E, Ligabue MB, Scaltriti L, Botti A, Artioli F, Mancuso P, Cardini F, Pandolfi P (2016) Acupuncture as an integrative approach for the treatment of hot flashes in women with breast cancer: a prospective multicenter randomized controlled trial (AcCliMaT). J Clin Oncol 34(15):1795–1802. https://doi.org/10.1200/JCO.2015.63.2893CrossRefPubMed Lesi G, Razzini G, Musti MA, Stivanello E, Petrucci C, Benedetti B, Rondini E, Ligabue MB, Scaltriti L, Botti A, Artioli F, Mancuso P, Cardini F, Pandolfi P (2016) Acupuncture as an integrative approach for the treatment of hot flashes in women with breast cancer: a prospective multicenter randomized controlled trial (AcCliMaT). J Clin Oncol 34(15):1795–1802. https://​doi.​org/​10.​1200/​JCO.​2015.​63.​2893CrossRefPubMed
5.
6.
Zurück zum Zitat Ben-Arye E, Segev Y, Galil G, Marom I, Gressel O, Stein N, Hirsh I, Samuels N, Schmidt M, Schiff E, Lurie I, Lavie O (2023) Acupuncture during gynecological oncology surgery: a randomized controlled trial assessing the impact of integrative therapies on perioperative pain and anxiety. Cancer 129(6):908–919. https://doi.org/10.1002/cncr.34542CrossRefPubMed Ben-Arye E, Segev Y, Galil G, Marom I, Gressel O, Stein N, Hirsh I, Samuels N, Schmidt M, Schiff E, Lurie I, Lavie O (2023) Acupuncture during gynecological oncology surgery: a randomized controlled trial assessing the impact of integrative therapies on perioperative pain and anxiety. Cancer 129(6):908–919. https://​doi.​org/​10.​1002/​cncr.​34542CrossRefPubMed
7.
Zurück zum Zitat Ben-Arye E, Hirsh I, Segev Y, Grach M, Master V, Eden A, Samuels N, Stein N, Gressel O, Ostrovsky L, Galil G, Schmidt M, Schiff E, Lavie O (2023) A randomized-controlled trial assessing the effect of intraoperative acupuncture on anesthesia-related parameters during gynecological oncology surgery. J Cancer Res Clin Oncol 149(11):8177–8189. https://doi.org/10.1007/s00432-023-04758-3CrossRefPubMed Ben-Arye E, Hirsh I, Segev Y, Grach M, Master V, Eden A, Samuels N, Stein N, Gressel O, Ostrovsky L, Galil G, Schmidt M, Schiff E, Lavie O (2023) A randomized-controlled trial assessing the effect of intraoperative acupuncture on anesthesia-related parameters during gynecological oncology surgery. J Cancer Res Clin Oncol 149(11):8177–8189. https://​doi.​org/​10.​1007/​s00432-023-04758-3CrossRefPubMed
10.
Zurück zum Zitat Coulombe MA, Décary E, Maximos S, Brulotte V, Drolet P, Tanoubi I, Issa R, Zaphiratos V, Verdonck O, Fortier LP, Godin N, Idrissi M, Raft J, Richebé P (2021) Assessing the antinociceptive effect of nitrous oxide to tetanic stimulation in anaesthetised patients with new intra-operative nociception monitors: an observational study. Eur J Anaesthesiol 38(5):512–523. https://doi.org/10.1097/EJA.0000000000001431CrossRefPubMed Coulombe MA, Décary E, Maximos S, Brulotte V, Drolet P, Tanoubi I, Issa R, Zaphiratos V, Verdonck O, Fortier LP, Godin N, Idrissi M, Raft J, Richebé P (2021) Assessing the antinociceptive effect of nitrous oxide to tetanic stimulation in anaesthetised patients with new intra-operative nociception monitors: an observational study. Eur J Anaesthesiol 38(5):512–523. https://​doi.​org/​10.​1097/​EJA.​0000000000001431​CrossRefPubMed
Metadaten
Titel
Fine-tuning the needle: analysis of acupuncturist response to alarming events during gynecological oncology surgery
verfasst von
Eran Ben-Arye
Galit Galil
Noah Samuels
Yakir Segev
Meirav Schmidt
Orit Gressel
Publikationsdatum
01.06.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2024
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08552-w

Weitere Artikel der Ausgabe 6/2024

Supportive Care in Cancer 6/2024 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.